Hepatitis B vaccination reliability in celiac disease

Hepatitis Monthly

Volumn 11, Issue 8, 2011, Pages 597-598

  Nejad, Mohammad Rostami ^a   Rostami, Kamran ^b   Zali, Mohammad Reza ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b DUDLEY GROUP OF HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Antibody; Hepatitis B virus; Vaccination

Indexed keywords

HEPATITIS B SURFACE ANTIBODY; HEPATITIS B VACCINE; HLA B8 ANTIGEN; HLA DQ2 ANTIGEN; HLA DQ8 ANTIGEN; HLA DR3 ANTIGEN;

ANTIBODY TITER; CELIAC DISEASE; CLINICAL ASSESSMENT; EDITORIAL; GENETIC MARKER; GLUTEN FREE DIET; HAPLOTYPE; HEPATITIS B; HUMAN; IMMUNE RESPONSE; IMMUNOGENETICS; INFECTION PREVENTION; KIDNEY FAILURE; RELIABILITY; VACCINATION; VACCINE FAILURE;

EID: 80052602121     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: 10.5812/kowsar.1735143X.761     Document Type: Editorial

References (15)

1. Ahishali E, Boztas G, Akyuz F, Ibrisim D, Poturoglu S, Pinarbasi B, et al. Response to hepatitis B vaccination in patients with celiac disease. Dig Dis Sci. 2008;53(8):2156-9.
2. Poland GA. Hepatitis B immunization in health care workers. Dealing with vaccine nonresponse. Am J Prev Med. 1998;15(1):73-7.
3. Safary A, Andre F. Over a decade of experience with a yeast recombinant hepatitis B vaccine. Vaccine. 1999;18(1-2):57-67.
4. Nemes É, Lefler É, Szegedi L, Kapitány A, Kovács JB, Balogh M, et al. Gluten intake interferes with the humoral immune response to recombinant hepatitis B vaccine in patients with celiac disease. Pediatrics. 2008;121(6):e1570.
5. Ertem D, Gonen I, Tanidir C, Ugras M, Yildiz A, Pehlivanoglu E, et al. The response to hepatitis B vaccine: does it differ in celiac disease? Eur J Gastroen Hepat. 2010;22(7):787.
6. Martinetti M, De Silvestri A, Belloni C, Pasi A, Tinelli C, Pistorio A, et al. Humoral response to recombinant hepatitis B virus vaccine at birth: role of HLA and beyond. Clin Immunol. 2000;97(3):234-40.
7. Stachowski J, Kramer J, Fust G, Maciejewski J, Baldamus CA, Petranyi GG. Relationship between the reactivity to hepatitis B virus vaccination and the frequency of MHC class I, II and III alleles in haemodialysis patients. Scand J Immunol. 1995;42(1):60-5.
8. Park SD, Markowitz J, Pettei M, Weinstein T, Sison CP, Swiss SR, et al. Failure to respond to hepatitis B vaccine in children with celiac disease. J Pediatr Gastroenterol Nutr. 2007;44(4):431-5.
9. Zali MR, Rostami Nejad M, Rostami K, Alavian SM. Liver complications in celiac disease. Hepat Mon. 2011; 11(5): 333-341.
10. Rostami Nejad M, Rostami K, Emami MH, Zali MR, Malekzadeh R. Epidemiology of Celiac Disease in Iran: A Review. Middle East. J Dig Dis. 2011;3(1):5-12.
11. van Heel DA, West J. Recent advances in coeliac disease. Gut. 2006;55(7):1037-46.
12. Kapitány A, Toth L, Tumpek J. Diagnostic significance of HLA DQ typing in patients with previous coeliac disease diagnosis based on histology alone. Aliment Pharm Therap. 2006;24(9):1395-402.
13. Ertekin V, Tosun M, Selimoǧlu M. Is there need to a new hepati{dotless}ti{dotless}s b vacci{dotless}ne schedule i{dotless}n chi{dotless}ldren wi{dotless}th celi{dotless}ac di{dotless}sease? Hepat Mon. 2011:[Epub a head of print].
14. Leonardi S, Spina M, Spicuzza L, Rotolo N, La Rosa M. Hepatitis B vaccination failure in celiac disease: is there a need to reassess current immunization strategies? Vaccine. 2009;27(43):6030-3.
15. Noh KW, Poland GA, Murray JA. Hepatitis B vaccine nonresponse and celiac disease. Am J Gastroenterol. 2003;98(10):2289-92.